Matches in Wikidata for { <http://www.wikidata.org/entity/Q74273941> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q74273941 description "assaig clínic" @default.
- Q74273941 description "clinical trial" @default.
- Q74273941 description "clinical trial" @default.
- Q74273941 description "clinical trial" @default.
- Q74273941 description "clinical trial" @default.
- Q74273941 description "ensaio clínico" @default.
- Q74273941 description "ensayo clínico" @default.
- Q74273941 description "ensayu clínicu" @default.
- Q74273941 description "essai clinique" @default.
- Q74273941 description "klinisch onderzoek" @default.
- Q74273941 description "клінічне випробування" @default.
- Q74273941 name "A First-in-human Phase Ia/b, Open Label, Multicentre, Dose Escalation Study of BI 905711 in Patients With Advanced Gastrointestinal Cancers" @default.
- Q74273941 name "A First-in-human Phase Ia/b, Open Label, Multicentre, Dose Escalation Study of BI 905711 in Patients With Advanced Gastrointestinal Cancers" @default.
- Q74273941 type Item @default.
- Q74273941 label "A First-in-human Phase Ia/b, Open Label, Multicentre, Dose Escalation Study of BI 905711 in Patients With Advanced Gastrointestinal Cancers" @default.
- Q74273941 label "A First-in-human Phase Ia/b, Open Label, Multicentre, Dose Escalation Study of BI 905711 in Patients With Advanced Gastrointestinal Cancers" @default.
- Q74273941 prefLabel "A First-in-human Phase Ia/b, Open Label, Multicentre, Dose Escalation Study of BI 905711 in Patients With Advanced Gastrointestinal Cancers" @default.
- Q74273941 prefLabel "A First-in-human Phase Ia/b, Open Label, Multicentre, Dose Escalation Study of BI 905711 in Patients With Advanced Gastrointestinal Cancers" @default.
- Q74273941 P1050 Q74273941-73EED9AE-57FC-4D2E-AEAD-92E1EC41B9B9 @default.
- Q74273941 P1132 Q74273941-2E811676-5D6A-4037-A8B8-3F0E5A14F98C @default.
- Q74273941 P1476 Q74273941-04D40734-760C-484F-8D76-E519808C18EF @default.
- Q74273941 P2899 Q74273941-C4B1EBDE-2F16-4057-819A-3A06FBE0F894 @default.
- Q74273941 P3098 Q74273941-072C6037-6949-403F-A669-E8AFB063BB07 @default.
- Q74273941 P31 Q74273941-FD33FDE4-8864-45D0-80A2-0B0FF5FC41C8 @default.
- Q74273941 P580 Q74273941-284E2A90-D552-4E19-9E1C-9C7194540658 @default.
- Q74273941 P582 Q74273941-A43C1E0C-B525-4E34-9D21-B71CE513B3DD @default.
- Q74273941 P6099 Q74273941-46BAFAD2-8BE2-4E37-A51F-F146CC34B180 @default.
- Q74273941 P8363 Q74273941-969B0C7C-0D05-49E8-A6F9-23ACEC9AEF13 @default.
- Q74273941 P1050 Q124292 @default.
- Q74273941 P1132 "+140" @default.
- Q74273941 P1476 "A First-in-human Phase Ia/b, Open Label, Multicentre, Dose Escalation Study of BI 905711 in Patients With Advanced Gastrointestinal Cancers" @default.
- Q74273941 P2899 "+18" @default.
- Q74273941 P3098 "NCT04137289" @default.
- Q74273941 P31 Q30612 @default.
- Q74273941 P580 "2019-12-13T00:00:00Z" @default.
- Q74273941 P582 "2022-11-04T00:00:00Z" @default.
- Q74273941 P6099 Q5452194 @default.
- Q74273941 P8363 Q78089383 @default.